SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.3B
1-Year Est. Return
34.1%
1 Year Est. Return
+34.1%
AUM
$3.3B
AUM Growth
+$644M
(+24%)
Holding
106
Top Buys
| 1 | +$40.1M | |
| 2 | +$34.3M | |
| 3 | +$32.7M | |
| 4 |
Salesforce
CRM
|
+$29.7M |
| 5 |
Home Depot
HD
|
+$27M |
Top Sells
| 1 | +$87.2M | |
| 2 | +$39.4M | |
| 3 | +$29.4M | |
| 4 |
Datadog
DDOG
|
+$24M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
+$19.9M |
Sector Composition
| 1 | Healthcare | 60.44% |
| 2 | Technology | 13.51% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arcutis Biotherapeutics
ARQT
$3.78B
| $198M | 5.06% |
10,478,000
-1,057,582
|
|
||
2
Benitec Biopharma
BNTC
$441M
| $139M | 3.55% |
9,876,506
|
|
||
3
Meta Platforms (Facebook)
META
$1.67T
| $126M | 3.21% |
170,973
+1,128
|
|
||
4
Legend Biotech
LEGN
$5.15B
| $125M | 3.19% |
3,818,009
+44,000
|
|
||
|
ETNB
5
DELISTED
89bio
ETNB
| $122M | 3.12% |
8,280,000
-5,930,000
|
|
||
6
Immatics
IMTX
$1.43B
| $102M | 2.62% |
12,030,129
|
|
||
7
Coca-Cola
KO
$303B
| $96.5M | 2.47% |
1,455,080
+221,850
|
|
||
8
GE Aerospace
GE
$308B
| $93.3M | 2.39% |
310,262
|
|
||
9
NVIDIA
NVDA
$4.44T
| $90.2M | 2.31% |
483,535
-16,027
|
|
||
10
EyePoint Pharmaceuticals
EYPT
$1.38B
| $88.2M | 2.26% |
6,192,715
-611,376
|
|
||
11
Biohaven
BHVN
$1.25B
| $84.4M | 2.16% |
5,620,271
|
|
||
12
Mineralys Therapeutics
MLYS
$3.09B
| $80.9M | 2.07% |
2,132,133
+387,641
|
|
||
|
13
Home Depot
HD
$349B
| $79.9M | 2.05% |
197,311
+66,590
|
|
||
14
TSMC
TSM
$1.51T
| $77.4M | 1.98% |
277,201
-23,200
|
|
||
15
Kura Oncology
KURA
$1.05B
| $71.8M | 1.84% |
8,116,000
|
|
||
16
Ferguson
FERG
$50.1B
| $68.8M | 1.76% |
306,260
+116,600
|
|
||
17
ArriVent BioPharma
AVBP
$1.01B
| $68.3M | 1.75% |
3,703,452
+290,664
|
|
||
18
Apellis Pharmaceuticals
APLS
$2.79B
| $65.1M | 1.67% |
2,878,000
|
|
||
19
Advanced Micro Devices
AMD
$350B
| $64.5M | 1.65% |
398,799
|
|
||
20
Oracle
ORCL
$611B
| $63.6M | 1.63% |
226,318
-4,410
|
|
||
21
Ultragenyx Pharmaceutical
RARE
$3.53B
| $60.7M | 1.55% |
2,019,000
-259,000
|
|
||
22
Bank of America
BAC
$396B
| $59.9M | 1.53% |
1,160,330
+233,140
|
|
||
23
KalVista Pharmaceuticals
KALV
$834M
| $58.1M | 1.49% |
4,768,712
-186,288
|
|
||
24
Apollo Global Management
APO
$78.9B
| $57.5M | 1.47% |
431,260
+2,800
|
|
||
25
Microsoft
MSFT
$3.56T
| $56.7M | 1.45% |
109,455
+10,627
|
|